Skip to main content
HR 4983 114th Congress House Health Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Health promotion and preventive care Indian social and development programs Minority health Prescription drugs

To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

Introduced: April 18, 2016 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 27, 2016
Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.
Apr 22, 2016
Referred to the Subcommittee on Health.
Apr 18, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 18, 2016
Introduced in House
 Plain-English summary Congressional Research Service

This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

What's happening now April 27, 2016

Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.

 Committees of jurisdiction 4